ABB India LimitedNSE: ABB

Press Release Aug 21 2023

· Issued by ABB India Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The project involves deploying ABB’s Distributed Control System to enhance operational efficiency and ensure quality control in biopharmaceutical production. This collaboration aims to position ABB as a key player in the pharmaceutical automation market, leveraging advanced technology for improved manufacturing processes. The press release serves to inform stock exchanges about this important development as required under regulatory obligations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ABB India Limited has informed the Exchange regarding a press release dated August 21, 2023, titled "ABB India bags breakthrough order for automating Reliance Life Sciences' biopharmaceutical facilities".

ABB India Limited on 6ix

Earlier from ABB India

Later from ABB India

All ABB India news releases